AMBRA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.531600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.135800E-01
Normal-vs-Stage2
8.406600E-01
Normal-vs-Stage3
2.319400E-01
Normal-vs-Stage4
6.595800E-01
Stage1-vs-Stage2
3.148400E-01
Stage1-vs-Stage3
3.435600E-01
Stage1-vs-Stage4
9.226200E-01
Stage2-vs-Stage3
1.020990E-01
Stage2-vs-Stage4
7.771000E-01
Stage3-vs-Stage4
3.672800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.226800E-01
Normal-vs-AfricanAmerican
7.897800E-01
Normal-vs-Asian
9.395800E-01
Caucasian-vs-AfricanAmerican
8.663800E-01
Caucasian-vs-Asian
6.335400E-01
AfricanAmerican-vs-Asian
8.827600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.514800E-01
Normal-vs-Female
6.237000E-01
Male-vs-Female
2.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.976600E-01
Normal-vs-Age(41-60Yrs)
9.674000E-01
Normal-vs-Age(61-80Yrs)
6.595200E-01
Normal-vs-Age(81-100Yrs)
5.201400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.267800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.328600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.647000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.573900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.265600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.311000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.395600E-01
Normal-vs-Daily Drinker
6.764600E-01
Normal-vs-Weekly Drinker
5.961600E-01
Normal-vs-Occasional Drinker
6.606000E-01
Normal-vs-Social Drinker
5.956000E-01
Non Drinker-vs-Daily Drinker
9.403000E-01
Non Drinker-vs-Weekly Drinker
8.746600E-01
Non Drinker-vs-Occasional Drinker
8.680100E-02
Non Drinker-vs-Social Drinker
7.233200E-01
Daily Drinker-vs-Weekly Drinker
8.350000E-01
Daily Drinker-vs-Occasional Drinker
1.228160E-01
Daily Drinker-vs-Social Drinker
8.120400E-01
Weekly Drinker-vs-Occasional Drinker
9.927800E-02
Weekly Drinker-vs-Social Drinker
6.640600E-01
Occasional Drinker-vs-Social Drinker
1.075450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.830200E-02
Normal-vs-Grade 2
5.697300E-03
Normal-vs-Grade 3
2.084600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.161730E-02
Grade 1-vs-Grade 3
5.016500E-03
Grade 1-vs-Grade 4
8.830200E-02
Grade 2-vs-Grade 3
5.042000E-01
Grade 2-vs-Grade 4
5.697300E-03
Grade 3-vs-Grade 4
2.084600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.037400E-01
Normal-vs-NonDiabetic
7.692000E-01
Diabetic-vs-NonDiabetic
6.013200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.222000E-01
Normal-vs-NoPancreatitis
6.904600E-01
Pancreatitis-vs-NoPancreatitis
2.061600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.187000E-01
Normal-vs-N1
7.937000E-01
N0-vs-N1
8.646200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.005800E-01
Normal-vs-TP53-NonMutant
8.284200E-01
TP53-Mutant-vs-TP53-NonMutant
5.301500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
